Lower airway obstruction is associated with increased morbidity in children with sickle cell disease

Jessica H Boyd1, Michael R DeBaun, Wayne J Morgan

  • 1Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA. boyd_j@kids.wustl.edu

Pediatric Pulmonology
|February 11, 2009
PubMed

Insights

Children with sickle cell disease (SCD) and lower airway obstruction experience twice the rate of pain or acute chest syndrome (ACS) hospitalizations. Increased surveillance is recommended for these children to monitor for future health issues.

Area of Science:

  • Pediatric Pulmonology
  • Hematology
  • Clinical Medicine

Background:

  • Pulmonary function abnormalities are not well-studied in relation to morbidity in pediatric sickle cell disease (SCD).
  • Morbidity in SCD is often assessed by hospitalizations for pain or acute chest syndrome (ACS).

Purpose of the Study:

  • To investigate the association between pulmonary function test results and the incidence of pain or ACS hospitalizations in children with SCD.
  • To determine if specific pulmonary function abnormalities predict future morbidity events in this population.

Main Methods:

  • Pulmonary function tests (PFTs) were performed on children aged 6-18 years with SCD.
  • PFT results were categorized into lower airway obstruction, restriction, or normal lung function.
  • Hospitalization rates for pain or ACS were compared between groups with abnormal PFTs and those with normal PFTs.

Main Results:

  • Children with lower airway obstruction had a significantly higher rate of hospitalizations for pain or ACS (2.5 vs. 1.2 per patient-year, RR 2.0, P=0.003).
  • No significant difference in morbidity rates was observed for children with restrictive lung function compared to those with normal lung function (1.4 vs. 1.2 per patient-year, RR 1.1, P=0.68).

Conclusions:

  • Lower airway obstruction in children with SCD is associated with increased future morbidity, specifically pain or ACS hospitalizations.
  • Children with SCD and lower airway obstruction warrant closer monitoring and increased surveillance for adverse health events.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: